Detection of Carcinogenic Human Papillomavirus in Specimens Collected with a Novel Self-Sampling Device-Reference-Cited by-同舟云学术

Detection of Carcinogenic Human Papillomavirus in Specimens Collected with a Novel Self-Sampling Device

Published:2006-06 Issue:6 Volume:44 Page:2158-2159
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Castle Philip E.¹,Aftab Asma²,Saint-Jean Gilbert³,Mendez Luis⁴

Affiliation:

1. Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, and Departments of

2. Family Medicine and Community Health

3. Epidemiology and Public Health

4. Obstetrics and Gynecology, University of Miami School of Medicine, Miami, Florida

Abstract

ABSTRACTWe compared the detection of carcinogenic human papillomavirus DNA in cervicovaginal specimens self-collected using a novel device to the detection in physician-collected cervical specimens from 137 women. The kappa value was 0.66 (95% confidence interval, 0.53 to 0.78), with an 83% overall test agreement and a 68% positive test agreement.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.02358-05

Reference9 articles.

1. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, et al. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst.87:796-802.

2. Fournier A. November 2002. U.S. patent 6 475 165.

3. Guido, R., M. Schiffman, D. Solomon, and L. Burke. 2003. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am. J. Obstet. Gynecol.188:1401-1405.

4. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K. V. Shah, P. J. Snijders, and C. J. Meijer. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med.348:518-527.

5. Schiffman, M., R. Herrero, A. Hildesheim, M. E. Sherman, M. Bratti, S. Wacholder, M. Alfaro, M. Hutchinson, J. Morales, M. D. Greenberg, and A. T. Lorincz. 2000. HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica. JAMA283:87-93.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concordance of Primary Human Papillomavirus Testing Among Clinicians and Patients: A Systematic Review;Journal of Women's Health;2023-10-01

2. Effect of Educational Intervention on Self-Sampling Acceptability and Follow-Up Paps in Border Dwelling Hispanic Females;Journal of Lower Genital Tract Disease;2018-10

3. Using a multimethod approach to develop implementation strategies for a cervical self-sampling program in Kenya;BMC Health Services Research;2017-03-21

4. Cervical cytological screening: Assessment of the Fournier®self-sampling device in a cervical pathology outpatient clinic;Diagnostic Cytopathology;2015-07-27

5. Acceptability and Usability of Self-Collected Sampling for HPV Testing Among African-American Women Living in the Mississippi Delta;Women's Health Issues;2013-03